Ocugen, Inc.
OCGN • NASDAQ
Ocugen, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shankar Musunuri, with a market cap of $613.2M.
CEOShankar Musunuri
Next Earnings
Upcoming earnings announcement for Ocugen, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.05
Revenue Estimate
$694.9K
Earnings History
Past 12 earnings reports for Ocugen, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | -$0.06Est: -$0.06 | 0.0% | -$193.0KEst: $1.1M | -117.3% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.07Est: -$0.05 | -40.0% | $1.8MEst: $744.0K | +135.5% | 10-Q |
| Aug 1, 2025 | Q2 2025 | -$0.05Est: -$0.05 | 0.0% | $1.4MEst: $770.0K | +78.3% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.05Est: -$0.06 | +16.7% | $1.5M | — | 10-Q |
| Mar 5, 2025 | Q4 2024 | -$0.05Est: -$0.05 | 0.0% | $764.0KEst: $300.0K | +154.7% | 10-K |
| Nov 8, 2024 | Q3 2024 | -$0.05Est: -$0.05 | 0.0% | $1.1MEst: $300.0K | +278.7% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.04Est: -$0.05 | +20.0% | $1.1M | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.05Est: -$0.06 | +16.7% | $1.0M | — | 10-Q |
| Apr 16, 2024 | Q4 2023 | -$0.04Est: -$0.06 | +33.3% | $6.0M | — | 10-K/A |
| Nov 9, 2023 | Q3 2023 | -$0.06Est: -$0.07 | +14.3% | - | — | — |
| Aug 21, 2023 | Q2 2023 | -$0.10Est: -$0.07 | -42.9% | - | — | — |
| May 5, 2023 | Q1 2023 | -$0.07Est: -$0.11 | +36.4% | - | — | — |